Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Human liver enzyme DHEA ST helps process minoxidil.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Finasteride breaks down into new compounds under acidic conditions.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Excessive iodine from a cystic fibrosis supplement can cause hypothyroidism.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Clobetasol nanocarriers can be effectively delivered to hair follicles, with uptake improved by massage and affected by particle type.

A specific gene variation increases the risk of high uric acid and cholesterol in young Mexican males.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Yellow Chinese chive extract helps protect mouse livers from damage caused by acetaminophen by activating an antioxidant pathway.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

A new compound effectively inhibits human 5α-reductase 1.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

LPA 4 helps control blood and lymph vessel development in zebrafish.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

The two finasteride tablets are bioequivalent.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Ceramide Synthase 4 is essential for normal hair growth and preventing hair loss.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.